Impact of a Pro-diversity Gut Microbiota Diet After a Bariatric Surgery on Gut Microbiota, Eating Behaviour and Sensory Function
BariaGut Taste
Randomised Controlled Trial Evaluating the Impact of a Pro-diversity Gut Microbiota Diet on Gut Microbiota, Eating Behaviour and Sensory Function in Patients Who Have Undergone Bariatric Surgery
1 other identifier
interventional
60
1 country
3
Brief Summary
Bariatric surgery is the most effective treatment for long-term weight loss and reducing obesity-related health risks. It alters the gastrointestinal tract as well as metabolic and hormonal functions, influencing eating behaviour. However, weight loss outcomes and long-term maintenance vary between patients, likely due to changes in the gut microbiota. Dietary recommendations aimed at improving microbiota diversity could help support sustained weight loss after surgery. The BariaGut Taste study aims to compare two dietary approaches following bariatric surgery: nutritional counselling promoting gut microbiota diversity versus standard nutritional counselling. One year after surgery, the study will evaluate differences in microbiota diversity, changes in food preferences and eating behaviours, sensory profiles (taste, smell), levels of digestive and gut hormones fasting, before and after eating, cardiometabolic parameters, mental health, physical activity, and more, to better understand Bariatric surgery is the most effective treatment for long-term weight loss and reducing obesity-related health risks. It alters the gastrointestinal tract as well as metabolic and hormonal functions, influencing eating behaviour. However, weight loss outcomes and long-term maintenance vary between patients, likely due to changes in the gut microbiota. Dietary recommendations aimed at improving microbiota diversity could help support sustained weight loss after surgery. The BariaGut Taste study aims to compare two dietary approaches following bariatric surgery: nutritional counselling promoting gut microbiota diversity versus standard nutritional counselling. One year after surgery, the study will evaluate differences in microbiota diversity, changes in food preferences and eating behaviours, sensory profiles (taste, smell), levels of digestive and gut hormones fasting, before and after eating, cardiometabolic parameters, mental health, physical activity, and more, to better understand the mechanisms that may explain variations in response to bariatric surgery. The BariaGut Taste study is a prospective, randomized, controlled trial with two parallel groups, involving non-diabetic patients aged 25 to 65 y undergoing either sleeve gastrectomy or Roux-en-Y gastric bypass. The trial will be conducted at the digestive surgery department of Edouard Herriot Hospital, the endocrinology-diabetes-nutrition department of Lyon Sud Hospital Center, and the Human Nutrition Research Center Rhône-Alpes. 60 participants are expected to be recruited, with 30 in each arm. Participants will be enrolled before surgery during a routine care visit with the surgeon. They will then undergo a metabolic assessment visit conducted exclusively for research purposes. This visit will allow to collect baseline data on primary outcomes via blood, expired air, and stool samples, anthropometric measurements, indirect calorimetry, a battery of questionnaires (TFEQ-21, DEBQ, PHQ-9, SF36, GSES, PANAS, ESUL, BES, DERS, GAD-7, IPAQ, BAQ, GSRS, sensory alterations, Bristol and Likert scales, and FNS), computerized food preference tests (LFPQ), and a standardized, video-recorded ad libitum buffet. Participants will be followed up at 3, 6, and 12 months after surgery through visits combining clinical care and research assessments. The dietary interventions specific to each group will be provided since the 3-month visit. The assessments conducted before surgery will be repeated at 6 and 12 months, also integrating clinical care objectives. Additional blood, stool, and adipose tissue samples collected during surgery will be stored to create a biobank.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Dec 2025
Typical duration for not_applicable
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 14, 2025
CompletedStudy Start
First participant enrolled
December 1, 2025
CompletedFirst Posted
Study publicly available on registry
December 5, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2029
ExpectedStudy Completion
Last participant's last visit for all outcomes
January 1, 2029
December 5, 2025
November 1, 2025
3.1 years
August 14, 2025
November 25, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Microbiota diversity 12 months after surgery
The change in the diversity of the microbiota (shot gun metagenomic analysis, counting the number of microbial genes), between before surgery and one year after surgery (delta) between the two dietary intervention groups.
Primary outcome will be assessed three times : before the surgery, 6 and 12 months after
Secondary Outcomes (99)
Eating behaviour during a standardised, filmed and validated ad libitum buffet : Food intake
Before the surgery and at 6 and 12 month after
Eating behaviour during a standardised, filmed and validated ad libitum buffet: Nutritional quality
Before the surgery and at 6 and 12 month after
Eating behaviour during a standardised, filmed and validated ad libitum buffet: Meal microstructure
Before the surgery and at 6 and 12 month after
Eating behaviour during a standardised, filmed and validated ad libitum buffet: Meal appreciation
Before the surgery and at 6 and 12 month after
Eating behaviour and preferences : Behaviors
Before the surgery and at 6 and 12 month after
- +94 more secondary outcomes
Study Arms (2)
Participants with nutritional counselling promoting gut microbiota diversity
EXPERIMENTALGiven the low amounts of food consumed during the first months after surgery, the specific nutritional recommendations for this group will be implemented starting 3 months post-surgery. Before 3 months, participants will receive the standard nutritional recommendations of routine care after bariatric surgery, identical to those given to the second group (see below). From 3 months onwards, participants will be encouraged to increase the consumption of certain specific foods known for their benefits on the gut microbiota, particularly for promoting gut bacterial diversity, in addition to maintaining protein intake and paying attention to food textures. Summary sheets will be provided to help recall the recommendations.
Participants with standard nutritional counselling
NO INTERVENTIONThe nutritional recommendations given to participants in this group are those applied in routine care within the Endocrinology, Diabetes, and Nutrition (EDN) Department for patients who have undergone sleeve gastrectomy or gastric bypass (Roux-en-Y). These recommendations aim to maintain adequate protein intake and are adapted to the recent changes in their digestive tract (pureed then mashed food during the first postoperative month). During the first 6 months, patients' food intake is significantly below their nutritional needs. So it is important to pay close attention to hydration (away from meals) and macronutrient intake, especially proteins, as well as the progression of food texture and chewing.
Interventions
Nutritional counseling
Eligibility Criteria
You may qualify if:
- Between 25 and 65 years old
- Undergoing either sleeve gastrectomy or Roux-en-Y gastric bypass
- With grade 3 obesity (BMI≥40 kg/m²) or with BMI≥35 kg/m² and at least one comorbidity likely to be improved after surgery, with the exception of type 2 diabetes
- Signed consent form
- Living less than an hour and 30 minutes from the hospital
- Presence of effective and stable contraception for women of childbearing potential
You may not qualify if:
- Type 2 diabetes
- Presence of a contraindication to bariatric surgery
- Presence of gastrointestinal pathologies with an inflammatory component, known gastroparesis, total gastrectomy, colectomy, exocrine pancreatic insufficiency, known endocrine pathologies inducing hyperglycaemia (uncontrolled dysthyroidism, acromegaly, hypercorticism, etc.), severe chronic renal insufficiency (\< 30mL/min), or hepatocellular insufficiency
- Claustrophobic
- Pregnant or breastfeeding women
- Taking an obesity treatment 3 months before surgery
- Daily taking of laxatives or drugs that can strongly interfere with the composition of the intestinal microbiota. If taken sporadically, the patient can be included at a distance (3 weeks) from the laxatives taken.
- Specific diets (vegetarian, vegan or without gluten)
- No French speaker
- Already included in other study
- Donated blood in the last two months
- Without freezer access
- With allergy or intolerance to food propose in ad libitum buffet
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (3)
Hospital Edouard Herriot, digestive surgery department
Lyon, 69310, France
Centre de recherche en nutrition humaine de Rhône-Alpes
Pierre-Bénite, 69310, France
Hôpital Lyon sud, Endocrinology Diabetes Nutrition department
Pierre-Bénite, 69310, France
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Berenice SEGRESTIN
CONTACT
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Masking Details
- Randomisation will be stratified according to sex, type of surgery and age.
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 14, 2025
First Posted
December 5, 2025
Study Start
December 1, 2025
Primary Completion (Estimated)
January 1, 2029
Study Completion (Estimated)
January 1, 2029
Last Updated
December 5, 2025
Record last verified: 2025-11